Routine

Chronic cough (cough >8 weeks) — diagnostic approach

chronic-cough · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Cough persisting >8 weeks (subacute 3-8 weeks, acute <3 weeks) in adults. After excluding red flags and reviewing CXR and smoking/drug history, the common triad of upper-airway cough syndrome, asthma/eosinophilic bronchitis, and GORD accounts for most non-smokers with a normal CXR. Empirical sequential treatment trials are standard.

Red flags

  • Haemoptysis
  • Weight loss, night sweats, fever (TB, malignancy, lymphoma)
  • Progressive breathlessness, finger clubbing, abnormal CXR
  • Hoarseness, dysphagia, aspiration, or stridor
  • Significant smoking history age >40 with new/changed cough
  • Recurrent pneumonia or focal signs

Assessment

Differential diagnosis

  • Upper-airway cough syndrome (post-nasal drip / rhinosinusitis)
  • Asthma / cough-variant asthma / non-asthmatic eosinophilic bronchitis
  • Gastro-oesophageal reflux (incl. non-acid/laryngopharyngeal)
  • ACE-inhibitor induced cough
  • Smoking / COPD / chronic bronchitis
  • Post-infectious cough, pertussis
  • Serious: lung cancer, TB, bronchiectasis, ILD, heart failure, foreign body
  • Chronic cough hypersensitivity syndrome (refractory/unexplained)

Investigations

  • History: duration, smoking, ACE inhibitor use, occupational/environmental triggers, reflux and rhinitis symptoms, red-flag features
  • CXR in all with chronic cough
  • Spirometry +/- bronchodilator reversibility; consider bronchial challenge or FeNO for cough-variant asthma/eosinophilic bronchitis
  • Review and STOP any ACE inhibitor (cough can take weeks to settle after withdrawal)
  • Targeted tests by suspicion: sputum for AFB/TB (esp. India), induced sputum eosinophils, ENT review/sinus imaging, HRCT if bronchiectasis/ILD suspected
  • Consider upper GI assessment/empirical reflux trial; bronchoscopy if localised wheeze/haemoptysis/foreign-body suspicion

Management

  • Identify and remove obvious causes: stop smoking, stop ACE inhibitor, treat occupational exposure
  • CXR for everyone; act on any abnormality or red flag urgently (2-week-wait cancer pathway if indicated)
  • If CXR normal and no red flags, treat the common causes with sequential empirical trials, reviewing response
  • Trial 1 - upper-airway cough syndrome: intranasal corticosteroid +/- antihistamine for several weeks
  • Trial 2 - asthma/eosinophilic bronchitis: inhaled corticosteroid trial (consider FeNO/sputum eosinophils)
  • Trial 3 - reflux: lifestyle measures +/- PPI trial (note limited evidence; address non-acid reflux)
  • Each trial run long enough (typically 4-8 weeks) before judging; treat concurrent causes
  • Refer to specialist cough/respiratory clinic if refractory or diagnosis unclear; consider neuromodulators for refractory chronic cough

Drugs & doses

Intranasal corticosteroid e.g. fluticasone/mometasone 1-2 sprays each nostril once daily (upper-airway cough syndrome) [verify local product]
Inhaled corticosteroid e.g. beclometasone 200-400 micrograms BD trial for suspected asthma/eosinophilic bronchitis [verify local dose]
Proton pump inhibitor e.g. omeprazole 20-40 mg PO once daily for a trial of several weeks if reflux suspected [verify local dose]
Stop ACE inhibitor; substitute an ARB if antihypertensive needed
Refractory chronic cough (specialist): low-dose morphine, gabapentin, or pregabalin as neuromodulators; speech-therapy cough control [verify eligibility & dose]

Disposition

Outpatient. Urgent respiratory/cancer-pathway referral for red flags or abnormal CXR. Specialist cough clinic for refractory cases.

Complications & pitfalls

  • Delayed diagnosis of lung cancer, TB, or ILD
  • Cough-related: syncope, rib fracture, incontinence, exhaustion, insomnia, social isolation
  • Unnecessary/escalating empirical therapy without benefit

Exam pearls

  • Chronic cough with a normal CXR in a non-smoker not on an ACE inhibitor is usually upper-airway cough syndrome, asthma/eosinophilic bronchitis, or reflux — treat these empirically (ACCP / ERS chronic cough guidelines).
  • Always stop an ACE inhibitor and allow up to several weeks for the cough to resolve before pursuing other causes.
  • In TB-endemic regions, actively exclude pulmonary TB in any chronic cough.
  • FeNO or induced-sputum eosinophils help identify steroid-responsive cough (cough-variant asthma / eosinophilic bronchitis).
  • Refractory/unexplained chronic cough is increasingly recognised as a cough-hypersensitivity syndrome responsive to neuromodulators and speech therapy (ERS 2020).
  • Give each empirical trial enough time and treat concurrent causes together.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.